Our Technology
HealthRegen is an Australian stem cell and diabetes regenerative medicine company, fully committed to developing a curative mature beta-cell therapy to people with type 1 diabetes thus regenerating their health.
HealthRegen embraces collaboration opportunities with other willing biotechnology and pharmaceutical companies, as well as world-renowned research and clinical institutions all over the world to develop its solutions, platform and products for diabetic sufferers.
Mature Beta Cell Therapy (BCT) Patent
Granted BCT is currently developed as a curative therapy for type 1 diabetes and a subset of insulin-dependent type 2 diabetes.
Intellectual Property
Issued patents, expanded know-how, trade secrets and many diabetes curative therapeutics-related proprietary technologies.
Research Publications
Collaborations
HealthRegen warmly embraces collaborations with other willing biotechnology and pharmaceutical companies, as well as world-renowned research and clinical institutions all over the world to develop her solutions, platform and products for people suffering from diabetes.